Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNONW) Change in Cash (2021 - 2026)

Tenon Medical's quarterly Change in Cash came in at $851000.0 in Q1 2026, down 77.46% year-on-year from $3.8 million in Q1 2025, and up 171.02% quarter-over-quarter from $314000.0 in Q4 2025.

Tenon Medical has reported Change in Cash for 6 years, with the latest figure at $851000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Change in Cash fell 77.46% year-over-year to $851000.0; the trailing twelve-month figure through Mar 2026 stood at -$5.7 million (down 196.3% YoY), and the FY2025 full-year result was -$2.8 million, down 167.66% from the prior year.
  • Change in Cash for Q1 2026 stood at $851000.0, up from $314000.0 in the prior quarter.
  • The five-year high for Change in Cash was $7.2 million in Q3 2024, with the low at -$4.7 million in Q3 2022.
  • Average Change in Cash over 5 years is $99411.8, with a median of $314000.0 recorded in 2025.
  • Year-over-year, Change in Cash soared 1007.22% in 2022 and slumped 190.53% in 2024.
  • Tracing TNONW's Change in Cash over 5 years: stood at -$1.0 million in 2022, then advanced by 7.91% to -$943000.0 in 2023, then slumped by 178.58% to -$2.6 million in 2024, then surged by 111.95% to $314000.0 in 2025, then soared by 171.02% to $851000.0 in 2026.
  • The last three Change in Cash figures came in at $851000.0 (Q1 2026), $314000.0 (Q4 2025), and -$4.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.72 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -1.13 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -136.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -504.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -492.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.23 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 15.90 Mn
10 Tenon Medical - - 945,000.00 851,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 851,000.00
Dec 31, 2025 314,000.00
Sep 30, 2025 -4.40 Mn
Jun 30, 2025 -2.47 Mn
Mar 31, 2025 3.78 Mn
Dec 31, 2024 -2.63 Mn
Sep 30, 2024 7.19 Mn
Jun 30, 2024 -2.42 Mn
Mar 31, 2024 1.96 Mn
Dec 31, 2023 -943,000.00
Sep 30, 2023 -2.48 Mn
Jun 30, 2023 2.67 Mn
Mar 31, 2023 1.05 Mn
Dec 31, 2022 -1.02 Mn
Sep 30, 2022 -4.72 Mn
Jun 30, 2022 3.20 Mn
Mar 31, 2022 1.76 Mn
Dec 31, 2021 1.51 Mn
Sep 30, 2021 -5.50 Mn
Jun 30, 2021 6.86 Mn
Mar 31, 2021 -194,000.00